With the tech space still attempting to digest wide-ranging fears associated with the possible bubble in artificial intelligence, innovators in other fields have also struggled. In particular, ...

“Suppose f is a quadratic function satisfying f(6)=0, f(-6)=0, and f(0)=10. Then f(4)= A. 5 B. 5.5 C. 5.555 D. 5.666 E. None of the above. “OK, come on up here to the board and do those computations ...

A sharp rise in students entering the University of California system without middle school-level math skills is raising alarms among educators. A new internal report from the University of California ...

The dollar is regaining its crown as one of the world’s most appealing assets, defying talk of a “Sell America” trade that had raised troubling questions about the outlook for the global reserve ...

President Donald Trump and the head of a key housing agency over the weekend mused about a 50-year mortgage backed by the government. The key question, beyond the logistics of actually introducing ...

William Pulte, director of the Federal Housing Finance Agency, said the White House is studying the introduction of a 50-year mortgage. President Donald Trump and the head of a key housing agency over ...

VAIL, Ariz. — Cienega High School Principal Kim Middleton woke up early last Saturday to urgent messages from district administrators. They told her to call immediately. A photo — in which Cienega ...

The original version of this story appeared in Quanta Magazine. The best perk of Alberto Maspero’s job, he says, is the view from his window. Situated on a hill above the ancient port city of Trieste, ...

With artificial intelligence continuing to dominate the technology ecosystem, it’s no wonder that integrated circuit foundry Taiwan Semiconductor (TSM) has benefited handsomely from the broader demand ...

A TKer subscriber recently pointed out that if your investment is down 20%, then you’d need a 25% gain from the current level to return to the initial level. For example, if your investment of $100 ...

Intellia Therapeutics has two promising late-stage pipeline candidates. The biotech has incredible hopes for these two medicines. However, its projections look too optimistic, and the stock carries ...